From the Department of Radiology, Istanbul Baskent University School of Medicine, Istanbul.
Exp Clin Transplant. 2022 Dec;20(12):1085-1093. doi: 10.6002/ect.2022.0244.
A hepatic vascular complication after liver transplant is a critical situation, often resulting in graft failure and potentially leading to patient death. Early diagnosis and treatment of vascular complications can provide prolonged graft survival and prohibit further complications. This study presents our experiences with endovascular treatment during the first week after liver transplant.
Between January 2012 and February 2021, 240 liver transplants were performed, with 43 patients having early endovascular treatment (37 men; mean age 27 ± 2.9 years) at a single center. Early endovascular interventions were carried out 1 to 7 days (mean ± SD of 2.7 ± 0.24 days) after transplant. Patients with vascular complications were grouped by arterial, venous, and portal complications. In addition, arterial complications were subgrouped by occlusive (hepatic artery thrombosis) and nonocclusive (hepatic artery stenosis/splenic artery steal syndrome) complications. Patients had median follow-up of 47 ± 4 months.
In the first week after liver transplant, vascular complications included splenic artery steal syndrome in 27 patients (62.7%), hepatic complications in 10 patients (23.2%) (7 with hepatic artery thrombosis, 3 with hepatic artery stenosis), hepatic venous outflow complications in 4 patients (9.3%), and portal vein complications in 2 patients (4.6%). Only 1 patient required revision surgery because of excessive arterial kinking; the remaining patients with arterial complications were successfully managed with multiple endovascular treatment attempts. Patients with splenic artery steal syndrome were treated by selective arterial embolization with coil devices. Resistivity index, peak systolic velocity of hepatic arteries, and portal vein maximal velocity significantly improved (P < .001). Patients with hepatic venous outflow and portal vein complications who had endovascular treatments and vascular structures maintained good results over follow-up.
Early endovascular intervention is feasible and safe for hepatic vascular complications following liver transplant, with high success treatment rates with advances in interventional radiology.
肝移植后发生肝血管并发症是一种危急情况,常导致移植物失功,并可能导致患者死亡。早期诊断和治疗血管并发症可以提供更长的移植物存活率,并防止进一步的并发症。本研究介绍了我们在肝移植后第一周进行血管内治疗的经验。
2012 年 1 月至 2021 年 2 月,在一家中心进行了 240 例肝移植,其中 43 例患者在肝移植后 1 至 7 天(平均 2.7 ± 0.24 天)进行了早期血管内治疗(37 例男性;平均年龄 27 ± 2.9 岁)。根据动脉、静脉和门静脉并发症对血管并发症患者进行分组。此外,动脉并发症还根据闭塞性(肝动脉血栓形成)和非闭塞性(肝动脉狭窄/脾动脉盗血综合征)并发症进行了亚组分析。患者中位随访时间为 47 ± 4 个月。
肝移植后第一周,血管并发症包括 27 例(62.7%)脾动脉盗血综合征、10 例(23.2%)肝并发症(7 例肝动脉血栓形成,3 例肝动脉狭窄)、4 例肝静脉流出道并发症(9.3%)和 2 例门静脉并发症(4.6%)。只有 1 例患者因动脉过度扭曲而需要再次手术,其余动脉并发症患者通过多次血管内治疗尝试成功得到了治疗。脾动脉盗血综合征患者采用选择性动脉栓塞术联合线圈装置治疗。肝动脉阻力指数、收缩期峰值流速和门静脉最大流速显著改善(P <.001)。接受血管内治疗且血管结构保持良好的肝静脉流出道和门静脉并发症患者在随访期间获得了良好的结果。
对于肝移植后发生的肝血管并发症,早期血管内介入是可行且安全的,随着介入放射学的进步,治疗成功率较高。